Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Natera, Inc. Director's Dealing 2021

Nov 2, 2021

30253_dirs_2021-11-01_8d707926-7aba-4f1b-836e-76d32d71025a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2021-11-01

Reporting Person: Chapman Steven Leonard (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-01 Common Stock S 80 $113.0050 Disposed 37023 Direct
2021-11-01 Common Stock S 420 $114.9138 Disposed 36603 Direct
2021-11-01 Common Stock S 1017 $116.1035 Disposed 35586 Direct
2021-11-01 Common Stock M 3052 $9.29 Acquired 38638 Direct
2021-11-01 Common Stock M 2084 $20.27 Acquired 40721 Direct
2021-11-01 Common Stock S 200 $113.01 Disposed 40521 Direct
2021-11-01 Common Stock S 1106 $114.7320 Disposed 39415 Direct
2021-11-01 Common Stock S 3389 $115.9887 Disposed 36026 Direct
2021-11-01 Common Stock S 440 $116.4970 Disposed 35586 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-11-01 Stock Option (right to buy) $9.29 M 3052 Disposed 2028-03-08 Common Stock (3052) Direct
2021-11-01 Stock Option (right to buy) $20.27 M 2083 Disposed 2029-04-11 Common Stock (2083) Direct

Footnotes

F1: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2021,

F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.01 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.56 to $115.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.60 to $116.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021, as amended on May 14, 2021.

F6: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.44 to $115.20 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.45 to $116.44 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.46 to $116.5950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.

F10: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.